Sustained elevation of resistin, NGAL and IL-8 are associated with severe sepsis/septic shock in the emergency department

Stephen P J Macdonald, Shelley F Stone, Claire L Neil, Pauline E van Eeden, Daniel M Fatovich, Glenn Arendts, Simon G A Brown, Stephen P J Macdonald, Shelley F Stone, Claire L Neil, Pauline E van Eeden, Daniel M Fatovich, Glenn Arendts, Simon G A Brown

Abstract

Objective: To identify biomarkers which distinguish severe sepsis/septic shock from uncomplicated sepsis in the Emergency Department (ED).

Methods: Patients with sepsis underwent serial blood sampling, including arrival in the ED and up to three subsequent time points over the first 24 hours. Messenger RNA (mRNA) levels of 13 genes representing arms of the innate immune response, organ dysfunction or shock were measured in peripheral blood leucocytes using quantitative PCR, and compared with healthy controls. Serum protein concentrations of targets differentially expressed between uncomplicated sepsis and severe sepsis/septic shock were then measured at each time point and compared between the two patient groups.

Results: Of 27 participants (median age 66 years, (IQR 35, 78)), 10 had uncomplicated sepsis and 17 had sepsis with organ failure (14 septic shock; 3 had other sepsis-related organ failures). At the time of first sample collection in the ED, gene expression of Interleukin (IL)-10 and Neutrophil Gelatinase Associated Lipocalin (NGAL) were significantly higher in severe sepsis than uncomplicated sepsis. Expression did not significantly change over time for any target gene. Serum concentrations of IL-6, IL-8, IL-10, NGAL and Resistin were significantly higher in severe sepsis than uncomplicated sepsis at the time of first sample collection in the ED, but only IL-8, NGAL and Resistin were consistently higher in severe sepsis compared to uncomplicated sepsis at all time points up to 24 h after presentation.

Conclusions: These mediators, produced by both damaged tissues and circulating leukocytes, may have important roles in the development of severe sepsis. Further work will determine whether they have any value, in addition to clinical risk parameters, for the early identification of patients that will subsequently deteriorate and/or have a higher risk of death.

Conflict of interest statement

Competing Interests: The authors have declared that no competing interests exist.

References

    1. Dellinger RP, Levy MM, Carlet JM, Bion J, Parker MM, et al. (2008) Surviving Sepsis Campaign: international guidelines for management of severe sepsis and septic shock: 2008. [Erratum appears in Intensive Care Med. 2008 Apr;34(4):783-5]. Intensive Care Medicine 34: 17–60.
    1. Bagshaw SM, Webb SA, Delaney A, George C, Pilcher D, et al. (2009) Very old patients admitted to intensive care in Australia and New Zealand: a multi-centre cohort analysis. Crit Care 13: R45.
    1. Carson SS (2003) The epidemiology of critical illness in the elderly. Crit Care Clin 19: : 605–617, v.
    1. Martin GS, Mannino DM, Moss M (2006) The effect of age on the development and outcome of adult sepsis. [see comment]. Critical Care Medicine 34: 15–21.
    1. Strehlow MC, Emond SD, Shapiro NI, Pelletier AJ, Camargo CA Jr (2006) National study of emergency department visits for sepsis, 1992 to 2001. Annals of Emergency Medicine 48: 326–331.
    1. Angus DC, van der Poll T (2013) Severe sepsis and septic shock. N Engl J Med 369: 840–851.
    1. Brenner T, Hofer S, Rosenhagen C, Steppan J, Lichtenstern C, et al. (2010) Macrophage migration inhibitory factor (MIF) and manganese superoxide dismutase (MnSOD) as early predictors for survival in patients with severe sepsis or septic shock. J Surg Res 164: e163–171.
    1. Christ-Crain M, Morgenthaler NG, Struck J, Harbarth S, Bergmann A, et al. (2005) Mid-regional pro-adrenomedullin as a prognostic marker in sepsis: an observational study. Crit Care 9: R816–824.
    1. Gustafsson A, Ljunggren L, Bodelsson M, Berkestedt I (2012) The Prognostic Value of suPAR Compared to Other Inflammatory Markers in Patients with Severe Sepsis. Biomark Insights 7: 39–44.
    1. Pierrakos C, Vincent JL (2010) Sepsis biomarkers: a review. Crit Care 14: R15.
    1. Nakamura T, Sato E, Fujiwara N, Kawagoe Y, Suzuki T, et al. (2009) Circulating levels of advanced glycation end products (AGE) and interleukin-6 (IL-6) are independent determinants of serum asymmetric dimethylarginine (ADMA) levels in patients with septic shock. Pharmacol Res 60: 515–518.
    1. Gille-Johnson P, Hansson KE, Gardlund B (2012) Clinical and laboratory variables identifying bacterial infection and bacteraemia in the emergency department. Scand J Infect Dis 44: 745–752.
    1. Bozza FA, Salluh JI, Japiassu AM, Soares M, Assis EF, et al. (2007) Cytokine profiles as markers of disease severity in sepsis: a multiplex analysis. Crit Care 11: R49.
    1. Shapiro NI, Trzeciak S, Hollander JE, Birkhahn R, Otero R, et al. (2009) A prospective, multicenter derivation of a biomarker panel to assess risk of organ dysfunction, shock, and death in emergency department patients with suspected sepsis. Crit Care Med 37: 96–104.
    1. Ip M, Rainer TH, Lee N, Chan C, Chau SS, et al. (2007) Value of serum procalcitonin, neopterin, and C-reactive protein in differentiating bacterial from viral etiologies in patients presenting with lower respiratory tract infections. Diagn Microbiol Infect Dis 59: 131–136.
    1. Punyadeera C, Schneider EM, Schaffer D, Hsu HY, Joos TO, et al. (2010) A biomarker panel to discriminate between systemic inflammatory response syndrome and sepsis and sepsis severity. J Emerg Trauma Shock 3: 26–35.
    1. Kofoed K, Andersen O, Kronborg G, Tvede M, Petersen J, et al. (2007) Use of plasma C-reactive protein, procalcitonin, neutrophils, macrophage migration inhibitory factor, soluble urokinase-type plasminogen activator receptor, and soluble triggering receptor expressed on myeloid cells-1 in combination to diagnose infections: a prospective study. Crit Care 11: R38.
    1. Wong HR, Lindsell CJ, Pettila V, Meyer NJ, Thair SA, et al. (2014) A multibiomarker-based outcome risk stratification model for adult septic shock*. Crit Care Med 42: 781–789.
    1. Lichtenstern C, Brenner T, Bardenheuer HJ, Weigand MA (2012) Predictors of survival in sepsis: what is the best inflammatory marker to measure? Curr Opin Infect Dis 25: 328–336.
    1. Travaglino F, De Berardinis B, Magrini L, Bongiovanni C, Candelli M, et al. (2012) Utility of Procalcitonin (PCT) and Mid regional pro-Adrenomedullin (MR-proADM) in risk stratification of critically ill febrile patients in Emergency Department (ED). A comparison with APACHE II score. BMC Infect Dis 12: 184.
    1. Freund Y, Delerme S, Goulet H, Bernard M, Riou B, et al... (2012) Serum lactate and procalcitonin measurements in emergency room for the diagnosis and risk-stratification of patients with suspected infection. Biomarkers.
    1. Arendts G, Stone SF, Fatovich DM, van Eeden P, MacDonald E, et al. (2012) Critical illness in the emergency department: lessons learnt from the first 12 months of enrolments in the Critical Illness and Shock Study. Emerg Med Australas 24: 31–36.
    1. Levy MM, Fink MP, Marshall JC, Abraham E, Angus D, et al. (2003) 2001 SCCM/ESICM/ACCP/ATS/SIS International Sepsis Definitions Conference. Intensive Care Med 29: 530–538.
    1. Charlson ME, Pompei P, Ales KL, MacKenzie CR (1987) A new method of classifying prognostic comorbidity in longitudinal studies: development and validation. J Chronic Dis 40: 373–383.
    1. Bustin SA, Benes V, Garson JA, Hellemans J, Huggett J, et al. (2009) The MIQE guidelines: minimum information for publication of quantitative real-time PCR experiments. Clin Chem 55: 611–622.
    1. Stone SF, Cotterell C, Isbister GK, Holdgate A, Brown SG (2009) Elevated serum cytokines during human anaphylaxis: Identification of potential mediators of acute allergic reactions. J Allergy Clin Immunol 124: : 786–792 e784.
    1. Pang SS, Le YY (2006) Role of resistin in inflammation and inflammation-related diseases. Cell Mol Immunol 3: 29–34.
    1. Aziz M, Jacob A, Yang WL, Matsuda A, Wang P (2013) Current trends in inflammatory and immunomodulatory mediators in sepsis. J Leukoc Biol 93: 329–342.
    1. Sunden-Cullberg J, Nystrom T, Lee ML, Mullins GE, Tokics L, et al. (2007) Pronounced elevation of resistin correlates with severity of disease in severe sepsis and septic shock. Crit Care Med 35: 1536–1542.
    1. Koch A, Gressner OA, Sanson E, Tacke F, Trautwein C (2009) Serum resistin levels in critically ill patients are associated with inflammation, organ dysfunction and metabolism and may predict survival of non-septic patients. Crit Care 13: R95.
    1. Constantin JM, Futier E, Perbet S, Roszyk L, Lautrette A, et al.. (2010) Plasma neutrophil gelatinase-associated lipocalin is an early marker of acute kidney injury in adult critically ill patients: a prospective study. Journal of Critical Care 25: : 176 e171–176.
    1. Lentini P, de Cal M, Clementi A, D'Angelo A, Ronco C (2012) Sepsis and AKI in ICU Patients: The Role of Plasma Biomarkers. Crit Care Res Pract 2012: 856401.
    1. Shapiro NI, Trzeciak S, Hollander JE, Birkhahn R, Otero R, et al.. (2010) The diagnostic accuracy of plasma neutrophil gelatinase-associated lipocalin in the prediction of acute kidney injury in emergency department patients with suspected sepsis. Ann Emerg Med 56: : 52–59 e51.
    1. Lindig S, Quickert S, Vodovotz Y, Wanner GA, Bauer M (2013) Age-independent co-expression of antimicrobial gene clusters in the blood of septic patients. Int J Antimicrob Agents 42 SupplS2–7.
    1. Herzum I, Renz H (2008) Inflammatory markers in SIRS, sepsis and septic shock. Curr Med Chem 15: 581–587.
    1. Lvovschi V, Arnaud L, Parizot C, Freund Y, Juillien G, et al. (2011) Cytokine profiles in sepsis have limited relevance for stratifying patients in the emergency department: a prospective observational study. PLoS One 6: e28870.

Source: PubMed

赞助者和合作者

医疗条件

药物干预

3
订阅